Premium
MannKind Corporation (MNKD)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Dr. Michael E. CastagnaCEO & Director | -34,96k | 123,05k | Sale to Issuer | 3,52 | 2,44M | -1,41% |
| 2026-05-12 | Dr. David B. ThomsonExec. VP, General Counsel & Secretary | -3,03k | 9,98k | Automatic Disposition | 3,29 | 564,55k | -0,53% |
| 2026-05-11 | Dr. David B. ThomsonExec. VP, General Counsel & Secretary | -12,39k | 43,60k | Sale to Issuer | 3,52 | 564,55k | -2,15% |
| 2026-05-12 | Mr. Steven B. BinderIndependent Director | -16,94k | 55,73k | Automatic Disposition | 3,29 | 546,76k | -3,01% |
| 2026-05-11 | Mr. Steven B. BinderIndependent Director | -5,56k | 19,57k | Sale to Issuer | 3,52 | 546,76k | -1,01% |
| 2026-05-11 | Dr. Stuart A. TrossChief People & Workplace Officer | -8,07k | 28,42k | Sale to Issuer | 3,52 | 730,47k | -1,09% |
| 2026-04-22 | Mr. Christopher B. PrentissCFO | -12,27k | 33,61k | Sale to Issuer | 2,74 | 54,11k | -18,48% |
| 2026-01-08 | Dr. Stuart A. TrossChief People & Workplace Officer | -47,01k | 297,55k | Automatic Disposition | 6,33 | 695,76k | -6,33% |
| 2025-12-24 | Dr. Michael E. CastagnaCEO & Director | -44,17k | 0,00 | Other Disposition | - | 2,46M | -1,76% |
| 2025-12-17 | Dr. Michael E. CastagnaCEO & Director | -65,80k | 96,07k | Derivative Exercise and Sale | 4,55 - 6,01 | 2,50M | - |
| 2025-12-12 | Dr. Michael E. CastagnaCEO & Director | -42,12k | 61,07k | Derivative Exercise and Sale | 4,55 - 6,00 | 2,50M | - |
| 2025-12-02 | Dr. Michael E. CastagnaCEO & Director | -107,92k | 110,08k | Derivative Exercise and Sale | 4,55 - 5,57 | 2,50M | - |
| 2025-12-02 | Dr. David B. ThomsonExec. VP, General Counsel & Secretary | -147,78k | 146,35k | Derivative Exercise and Sale | 4,55 - 5,57 | 557,47k | - |
| 2025-11-14 | Mr. Sanjay SinghExec. VP of Technical Operations | -18,78k | 94,45k | Automatic Disposition | 5,03 | 150,46k | -11,10% |
| 2025-10-31 | Mr. Sanjay SinghExec. VP of Technical Operations | -17,07k | 95,43k | Sale to Issuer | 5,59 | 169,24k | -9,16% |
| 2025-09-16 | Dr. Stuart A. TrossChief People & Workplace Officer | -47,00k | 250,98k | Automatic Disposition | 5,34 | 747,76k | -5,91% |
| 2025-07-16 | Mr. Steven B. BinderIndependent Director | -75,37k | 296,95k | Automatic Disposition | 3,94 | 546,76k | -12,11% |
| 2025-07-15 | Mr. Steven B. BinderIndependent Director | -19,38k | 74,62k | Sale to Issuer | 3,85 | 546,76k | -3,42% |
| 2025-07-15 | Dr. Burkhard BlankInitié | -9,56k | 36,79k | Sale to Issuer | 3,85 | 259,04k | -3,56% |
| 2025-07-15 | Dr. Michael E. CastagnaCEO & Director | -111,28k | 428,41k | Sale to Issuer | 3,85 | 2,50M | -4,25% |
| 2025-07-15 | Mr. Sanjay SinghExec. VP of Technical Operations | -15,45k | 59,48k | Sale to Issuer | 3,85 | 131,68k | -10,50% |
| 2025-07-15 | Dr. Stuart A. TrossChief People & Workplace Officer | -28,06k | 108,02k | Sale to Issuer | 3,85 | 782,01k | -3,46% |
| 2025-07-16 | Dr. David B. ThomsonExec. VP, General Counsel & Secretary | -7,47k | 29,42k | Automatic Disposition | 3,94 | 557,47k | -1,32% |
| 2025-07-15 | Dr. David B. ThomsonExec. VP, General Counsel & Secretary | -30,36k | 116,89k | Sale to Issuer | 3,85 | 557,47k | -5,16% |
| 2025-07-15 | Ms. Lauren M. SabellaInitié | -11,90k | 45,80k | Sale to Issuer | 3,85 | 136,47k | -8,02% |
| 2025-07-15 | Mr. Christopher B. PrentissCFO | -11,54k | 44,43k | Sale to Issuer | 3,85 | 24,50k | -32,02% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
